Evaluation of multiple real-time PCR tests on nasal samples in a Large MRSA surveillance program

American Journal of Clinical Pathology

Volumn 143, Issue 5, 2015, Pages 652-658

  Patel, Parul A ^a   Robicsek, Ari ^a,b   Grayes, Althea ^a   Schora, Donna M ^a   Peterson, Kari E ^a   Wright, Marc O ^a   Peterson, Lance R ^a,b  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

MRSA surveillance; Real time PCR; Staphylococcus aureus

Indexed keywords

AGAR MEDIUM; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; EVALUATION STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOSE SMEAR; POLYMERASE CHAIN REACTION SYSTEM; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; ALGORITHM; CLINICAL TRIAL; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTICENTER STUDY; NOSE CAVITY; PROCEDURES; STAPHYLOCOCCAL INFECTIONS;

BACTERIAL DNA;

ALGORITHMS; DNA, BACTERIAL; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NASAL CAVITY; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS;

EID: 84937130512     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPMDY32ZTDXPFC     Document Type: Article

References (37)

1. Delorme T, Rose S, Senita J, et al. Epidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in northeastern Ohio. Am J Clin Pathol. 2009;132:668-677.
2. Mertz D, Dafoe N, Walter SD, et al. Effect of a multifaceted intervention on adherence to hand hygiene among healthcare workers: a cluster-randomized trial. Infect Contr Hosp Epidemiol. 2010;31:1170-1176.
3. Peterson LR, Hacek DM, Robicsek A. 5 Million Lives Campaign. Case study: an MRSA intervention at Evanston Northwestern Healthcare. Jt Comm J Qual Patient Saf. 2007;33:732-738.
4. Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173:2039-2046.
5. Ridgway JP, Peterson LR, Brown EC, et al. Clinical significance of methicillin-resistant Staphylococcus aureus colonization on hospital admission: one-year infection risk. PLoS One. 2013;8:e79716.
6. Datta R, Huang SS. Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis. 2008;47:176-181.
7. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis. 2003;36:281-285.
8. Hacek DM, Paule SM, Thomson RB, et al. Implementation of a universal admission surveillance and decolonization program for methicillin-resistant Staphylococcus aureus (MRSA) reduces the number of MRSA and total S. aureus isolates reported by the clinical laboratory. J Clin Microbiol. 2009;47:3749-3752.
9. Lee AS, Cooper BS, Malhotra-Kumar S, et al. Comparison of strategies to reduce methicillin-resistant Staphylococcus aureus rates in surgical patients: a controlled multicentre intervention trial. BMJ Open. 2013;3:e003126.
10. Huskins WC, Huckabee CM, O'Grady NP, et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med. 2011;364:1407-1418.
11. Peterson LR, Diekema DJ. To screen or not to screen for methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2010;48:683-689.
12. Stephen MK, Martin EE, Loretta AS, et al. Zeroing in on methicillin-resistant Staphylococcus aureus: US Department of Veterans Affairs' MRSA Prevention Initiative. Am J Infect Contr. 2013;41:456-458.
13. Kallen AJ, Mu Y, Bulens S, et al; Active Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program. Health care-associated invasive MRSA infections, 2005-2008. JAMA. 2010;304:641-648.
14. Michael ZD, Medvedev S, Samuel FH, et al. Increasing burden of methicillin-resistant Staphylococcus aureus hospitalizations at US academic medical centers, 2003-2008. Infect Contr Hosp Epidemiol. 2012;33:782-789.
15. Patel PA, Ledeboer NA, Ginocchio CC, et al. Performance of the BD GeneOhm MRSA achromopeptidase assay for real-time PCR detection of methicillin-resistant Staphylococcus aureus in nasal specimens. J Clin Microbiol. 2011;49:2266-2268.
16. Peterson LR, Liesenfeld O, Woods CW, et al. Multicenter evaluation of the LightCycler methicillin-resistant Staphylococcus aureus (MRSA) advanced test as a rapid method for detection of MRSA in nasal surveillance swabs. J Clin Microbiol. 2010;48:1661-1666.
17. Polisena J, Chen S, Cimon K, et al. Clinical effectiveness of rapid tests for methicillin resistant Staphylococcus aureus (MRSA) in hospitalized patients: a systematic review. BMC Infect Dis. 2011;11:336.
18. Malhotra-Kumar S, Haccuria K, Michiels M, et al. Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species. J Clin Microbiol. 2008;46:1577-1587.
19. Marlowe EM, Wolk DM. GeneXpert testing: applications for clinical microbiology, part II. Clin Microbiol Newsl. 2008;30:183-188.
20. Roche. LightCycler® MRSA Advanced Test. Basel, Switzerland: F. Hoffmann-La Roche; 2011. http://www.roche.com/products/product-details.htm?type=product&id=109. Accessed March 20, 2015.
21. Becton Dickinson. BD MAX MRSA assay [package insert]. http://www.bd.com/resource.aspx?idx=25960. Accessed March 20, 2015.
22. Cepheid. Xpert® MRSA assay [package insert]. http://www.cepheid.com/us/cepheid-solutions/clinical-ivd-tests/healthcare-associated-infections/xpert-mrsa. Accessed March 20, 2015.
23. Paule SM, Hacek DM, Kufner B, et al. Performance of the BD GeneOhm methicillin-resistant Staphylococcus aureus test before and during high-volume clinical use. J Clin Microbiol. 2007;45:2993-2998.
24. Lee TA, Hacek DM, Stroupe KT, et al. Three surveillance strategies for vancomycin-resistant enterococci in hospitalized patients: detection of colonization efficiency and a cost-effectiveness model. Infect Control Hosp Epidemiol. 2005;26:39-46.
25. Schroeder LF, Robilotti E, Peterson LR, et al. Economic evaluation of laboratory testing strategies for hospital-associated Clostridium difficile infection. J Clin Microbiol. 2014;52:489-496.
26. Robicsek A, Beaumont JL, Paule SM, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med. 2008;148:409-418.
27. Hardy K, Price C, Szczepura A, et al. Reduction in the rate of methicillin-resistant Staphylococcus aureus acquisition in surgical wards by rapid screening for colonization: a prospective, cross-over study. Clin Microbiol Infect. 2010;16:333-339.
28. Bischof LJ, Lapsley L, Fontecchio K, et al. Comparison of chromogenic media to BD GeneOhm methicillin resistant Staphylococcus aureus (MRSA) PCR for detection of MRSA in nasal swabs. J Clin Microbiol. 2009;47:2281-2283.
29. Van Hal SJ, Jennings Z, Stark D, et al. MRSA detection: comparison of two molecular methods (BD GeneOhm PCR assay and Easy-Plex) with two selective MRSA agars (MRSA-ID and Oxoid MRSA) for nasal swabs. Eur J Clin Microbiol Infect Dis. 2009;28:47-53.
30. Wolk DM, Picton E, Johnson D, et al. Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J Clin Microbiol. 2009;47:758-764.
31. Hospital utilization (in non-federal short stay hospitals). http://www.cdc.gov/nchs/fastats/hospital.htm. Accessed March 20, 2015.
32. Chu H, Lofgren ET, Halloran ME, et al. Performance of rapid influenza H1N1 diagnostic tests: a meta-analysis. Influenza Other Respir Viruses. 2012;6:80-86.
33. Yam WC, Siu GK, Ho PL, et al. Evaluation of the LightCycler methicillin-resistant Staphylococcus aureus (MRSA) advanced test for detection of MRSA nasal colonization. J Clin Microbiol. 2013;51:2869-2874.
34. Hon PY, Chan KS, Holden MT, et al. Arginine catabolic mobile element in methicillin-resistant Staphylococcus aureus (MRSA) clonal group ST239-MRSA-III isolates in Singapore: implications for PCR-based screening tests. Antimicrob Agents Chemother. 2013;57:1563-1564.
35. Sanford MD, Widmer AF, Bale MJ, et al. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 1994;19:1123-1128.
36. Mehta MS, Hacek DM, Kufner BA, et al. Dose-ranging study to assess the application of intranasal 2% mupirocin calcium ointment to eradicate Staphylococcus aureus nasal colonization. Surg Infect. 2013;14:69-72.
37. Shenoy ES, Kim J, Rosenberg ES, et al. Discontinuation of contact precautions for methicillin-resistant Staphylococcus aureus: a randomized controlled trial comparing passive and active screening with culture and polymerase chain reaction. Clin Infect Dis. 2013;57:176-184.